{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:25Z","timestamp":1793600845286,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neubiorev.2026.106655","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T23:31:39Z","timestamp":1774135899000},"page":"106655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The endocannabinoid system in obsessive-compulsive disorder: A scoping review"],"prefix":"10.1016","volume":"185","author":[{"given":"Hanan","family":"Idd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil Angela","family":"Dela Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenelle","family":"Athansius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siya","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Feusner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6838-4114","authenticated-orcid":false,"given":"Stefan","family":"Kloiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2026.106655_bib1","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/NDT.S62785","article-title":"Animal models of obsessive\u2013compulsive disorder: utility and limitations","volume":"11","author":"Alonso","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neubiorev.2026.106655_bib2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). Arlington, VA: Author.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"10.1016\/j.neubiorev.2026.106655_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.physbeh.2014.06.003","article-title":"\u0392-caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice","volume":"135","author":"Bahi","year":"2014","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-024-02829-8","article-title":"Selective alterations of endocannabinoid system genes expression in obsessive compulsive disorder","volume":"14","author":"Bellia","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"52","key":"10.1016\/j.neubiorev.2026.106655_bib6","doi-asserted-by":"crossref","first-page":"19115","DOI":"10.1073\/pnas.0509494102","article-title":"Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor","volume":"102","author":"Berghuis","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106655_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(86)90051-8","article-title":"Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice","volume":"126","author":"Broekkamp","year":"1986","journal-title":"Eur. J. Pharmacol."},{"issue":"6604","key":"10.1016\/j.neubiorev.2026.106655_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"issue":"6507","key":"10.1016\/j.neubiorev.2026.106655_bib9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.neubiorev.2026.106655_bib10","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2026.106655_bib11","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6493","article-title":"Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors","volume":"7","author":"Diniz","year":"2019","journal-title":"PeerJ"},{"issue":"9\u201310","key":"10.1016\/j.neubiorev.2026.106655_bib12","article-title":"Dopamine-transporter heterozygous rats carrying maternal wild-type allele are more vulnerable to the development of compulsive behavior","volume":"76","author":"Festucci","year":"2022","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106655_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pnpbp.2010.11.027","article-title":"Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice","volume":"35","author":"Gomes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106655_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pnpbp.2012.04.011","article-title":"Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice","volume":"38","author":"Gould","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106655_bib15","unstructured":"Wells, G.A., Shea,\u00a0B., O\u2019Connell,\u00a0D., Peterson,\u00a0J.,\u00a0Welch, V., Losos, M., &\u00a0Tugwell,\u00a0P. (2011). The Newcastle\u2011Ottawa Scale (NOS) for assessing the quality of non\u2011randomized studies in meta\u2011analyses. Ottawa Hospital Research Institute."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106655_bib16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.neuron.2016.04.043","article-title":"Endocannabinoid modulation of orbitostriatal circuits gates habit formation","volume":"90","author":"Gremel","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3264","article-title":"Orbitofrontal and striatal circuits dynamically encode the shift between goal-directed and habitual actions","volume":"4","author":"Gremel","year":"2013","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106655_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neubiorev.2026.106655_bib20","article-title":"The endocannabinoid system in obsessive-compulsive disorder: a scoping review [OSF preregistration]","author":"Idd","year":"2025","journal-title":"Open Sci. Framew."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106655_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jnc.13267","article-title":"Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety-like behavior","volume":"135","author":"Imperatore","year":"2015","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106655_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/aur.108","article-title":"Autism spectrum and obsessive\u2013compulsive disorders: OC behaviors, phenotypes and genetics","volume":"2","author":"Jacob","year":"2009","journal-title":"Autism Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106655_bib23","first-page":"1281","article-title":"Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: a randomized, placebo-controlled trial","volume":"34","author":"Kayser","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib24","first-page":"219","article-title":"Cannabinoid augmentation of exposure-based psychotherapy for obsessive\u2013compulsive disorder","volume":"10","author":"Kayser","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106655_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2010.12.002","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay","volume":"98","author":"Kinsey","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106655_bib27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/da.20332","article-title":"Gender differences in obsessive\u2013compulsive symptom dimensions","volume":"25","author":"Labad","year":"2008","journal-title":"Depress Anxiety"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology","volume":"5","author":"Levac","year":"2010","journal-title":"Implement. Sci."},{"key":"10.1016\/j.neubiorev.2026.106655_bib29","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291725102171","article-title":"Heterogeneity of brain functional connectivity, transcriptome, and neurotransmitter profiles in major depressive disorder","volume":"55","author":"Li","year":"2025","journal-title":"Psychol. Med."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106655_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106655_bib31","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cog. Neurosci. Neuroimaging"},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106655_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106655_bib33","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106655_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11920-019-1015-2","article-title":"Epidemiological and clinical gender differences in OCD","volume":"21","author":"Mathes","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106655_bib35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2019.07.034","article-title":"Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: a randomized, controlled experimental medicine trial","volume":"87","author":"Mayo","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106655_bib36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biopsych.2021.07.019","article-title":"Targeting the endocannabinoid system in the treatment of posttraumatic stress disorder: a promising case of preclinical\u2013clinical translation?","volume":"91","author":"Mayo","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106655_bib37","article-title":"Cannabinoid ligands targeting TRP channels","volume":"11","author":"Muller","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","article-title":"Evaluation of marble-burying behavior as a model of anxiety","volume":"38","author":"Njung\u2019e","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106655_bib39","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41386-020-00936-w","article-title":"The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial","volume":"46","author":"Paulus","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2026.106655_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108626","article-title":"Endocannabinoids, cannabinoids and the regulation of anxiety","volume":"195","author":"Petrie","year":"2021","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106655_bib41","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106655_bib42","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cercor\/bhm161","article-title":"Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex","volume":"18","author":"Rubino","year":"2008","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuropharm.2008.04.013","article-title":"Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats","volume":"55","author":"Rueda-Orozco","year":"2008","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106655_bib44","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1176\/appi.ajp.2007.07061016","article-title":"Improvement in refractory obsessive compulsive disorder with Dronabinol","volume":"165","author":"Schindler","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106655_bib45","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41386-020-00888-1","article-title":"The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study","volume":"46","author":"Schmidt","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106655_bib46","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1038\/s41380-020-01007-8","article-title":"Toward a neurocircuit-based taxonomy to guide treatment of obsessive\u2013compulsive disorder","volume":"26","author":"Shephard","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106655_bib47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopsych.2017.11.036","article-title":"Role of striatal direct pathway 2-arachidonoylglycerol signaling in sociability and repetitive behavior","volume":"84","author":"Shonesy","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106655_bib48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"6644","key":"10.1016\/j.neubiorev.2026.106655_bib49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.106655_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00681","article-title":"Cannabis improves obsessive-compulsive disorder\u2014case report and review of the literature","volume":"11","author":"Szejko","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106655_bib51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"Thomas","year":"2009","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106655_bib52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"Prisma extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106655_bib53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2011.04.031","article-title":"Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice","volume":"223","author":"Umathe","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"5\u20136","key":"10.1016\/j.neubiorev.2026.106655_bib54","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.neuropharm.2011.12.030","article-title":"Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor","volume":"62","author":"Umathe","year":"2012","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106655_bib55","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1038\/s41380-020-00905-1","article-title":"Role of endocannabinoid signaling in a septohabenular pathway in the regulation of anxiety- and depressive-like behavior","volume":"26","author":"Vickstrom","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"6828","key":"10.1016\/j.neubiorev.2026.106655_bib56","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","article-title":"Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses","volume":"410","author":"Wilson","year":"2001","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106655_bib57","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s12264-024-01252-9","article-title":"Neurobiology of obsessive\u2013compulsive disorder from genes to circuits: Insights from animal models","volume":"40","author":"Zhang","year":"2024","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neubiorev.2026.106655_bib58","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2016.09.012","article-title":"Rodent models of obsessive compulsive disorder: evaluating validity to interpret emerging neurobiology","volume":"345","author":"Zike","year":"2017","journal-title":"Neuroscience"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426001120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426001120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:37:16Z","timestamp":1793597836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763426001120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"alternative-id":["S0149763426001120"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106655","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The endocannabinoid system in obsessive-compulsive disorder: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106655"}}